A high-cost therapy coupled with a complex and evolving reimbursement model has created what some are calling a healthcare crisis for tens of thousands of chronically ill patients.
Some commonly held misunderstandings about reimbursement are clarified, including reimbursement for IVIG, SCIG, affordability and assistance.
